Symptom aggravation after withdrawal of metal chelating agent therapy in patients with Wilson's disease

Symptom aggravation after withdrawal of metal chelating agent therapy in patients with Wilson's disease

Abstract Objective To study the aggravation of clinical symptoms after discontinuation of metal chelating agent therapy in Wilson's disease (WD) patients, analyze the causes of aggravation, and observe the prognosis. Methods 40 WD patients (cerebral type 30 cases and hepatic type 10 cases) who...

Full description

Bibliographic Details
Main Authors: Xiangxue Zhou, Jian Liao, Yinjie Liu, Haolin Qin, Xia Xiao
Format: Article
Language:English
Published: Wiley 2023-09-01
Series:Brain and Behavior
Subjects:
disease stage
drug discontinuance
metal chelating agent
symptoms aggravated
Wilson disease
Online Access:https://doi.org/10.1002/brb3.3170

Internet

https://doi.org/10.1002/brb3.3170

Similar Items